All In Biotech

Free tool

FAERS Monitor: Toprol-Xl

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019962 or its brand name (Toprol-Xl, Metoprolol Succinate). Reports on generic versions are filed under their own applications.

Reports

88,225

Serious

54,921

62% of reports

Hospitalization

29,946

Death reported

8,049

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue6,628
  • diarrhoea5,434
  • nausea5,124
  • dyspnoea5,068
  • drug ineffective4,420
  • dizziness4,356
  • off label use4,331
  • headache4,004
  • death3,608
  • asthenia3,350
  • pain3,286
  • fall3,171
  • cough2,677
  • pneumonia2,660
  • malaise2,517

Reports by year received

View as table
YearReports
2004589
2005538
2006696
20071,529
2008890
20091,252
2010983
20111,876
20123,087
20131,535
20144,012
20155,011
20165,332
20175,626
20186,458
20196,109
20205,687
20215,015
20225,570
20235,880
20246,865
20257,767
20265,916

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,965,934 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
coughSignal2,6772.32.21,947
fallSignal3,1712.32.22,301
dyspnoeaSignal5,0682.12.13,152
astheniaSignal3,3502.12.12,036
dizzinessSignal4,3562.12.02,519
fatigueSignal6,6282.02.03,609
diarrhoeaSignal5,4342.02.02,843
pneumonia2,6602.01.91,272
nausea5,1241.51.51,023
headache4,0041.51.5743
malaise2,5171.41.3255
pain3,2861.31.2202
off label use4,3311.21.1123
death3,6081.01.00
drug ineffective4,4200.80.8238

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.